Back to Search
Start Over
The ERM protein moesin regulates natural killer cell homeostasis in vivo.
- Source :
-
Cellular immunology [Cell Immunol] 2022 Jan; Vol. 371, pp. 104456. Date of Electronic Publication: 2021 Nov 13. - Publication Year :
- 2022
-
Abstract
- Moesin is a member of the ezrin-radixin-moesin (ERM) family of proteins that link plasma membrane proteins with actin filaments in the cell cortex. Hemizygous mutations in the X-linked moesin gene are associated with primary immunodeficiency with T and B cell lymphopenia, which also affects natural killer (NK) cells in most cases. We previously showed that moesin deficiency in mice substantially affects lymphocyte homeostasis, but its impact on NK cells remains unexplored. Here, we found that in moesin-deficient mice, NK cells were decreased in the peripheral blood and bone marrow but increased in the spleen. Analysis of female heterozygous mice showed a selective advantage for moesin-expressing NK cells in the blood. Moesin-deficient NK cells exhibited increased cell death and impaired signaling in response to IL-15, suggesting that moesin regulates NK cell survival through IL-15-mediated signaling. Our findings thus identify moesin as an NK cell homeostasis regulator in vivo.<br /> (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Subjects :
- Actin Cytoskeleton metabolism
Animals
Apoptosis genetics
Cell Membrane metabolism
Lymphocyte Count
Lymphopenia genetics
Membrane Proteins metabolism
Mice
Mice, Inbred C57BL
Mice, Knockout
Microfilament Proteins immunology
Primary Immunodeficiency Diseases genetics
Primary Immunodeficiency Diseases immunology
Signal Transduction immunology
Spleen cytology
Homeostasis immunology
Interleukin-15 immunology
Killer Cells, Natural immunology
Microfilament Proteins genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1090-2163
- Volume :
- 371
- Database :
- MEDLINE
- Journal :
- Cellular immunology
- Publication Type :
- Academic Journal
- Accession number :
- 34798556
- Full Text :
- https://doi.org/10.1016/j.cellimm.2021.104456